VIVACE

VIVACE is an EU-financed Marie Slodowska-Curie Action (MSCA) Doctorate Network focused on the importance, opportunities and challenges linked to the implementation of poultry vaccination in Europe against avian influenza viruses (AIVs)

Carte - LOGOS-14012025.png

Over the last seven years, outbreaks of AIVs have been occurring more frequently and have been larger in size, coinciding with an increasing demand for poultry by an expanding world population.

The VIVACE project aims to train a new generation of scientists to assess the impacts of vaccination on:

  1. Viral Evolution: Monitoring vaccine-induced protection against circulating avian influenza virus (AIV) strains and evaluating how vaccination affects viral evolution and pandemic risks (WP1).
  2. Transmission and Management: Studying AIV transmission, developing advanced surveillance tools, and optimizing vaccination strategies to reduce disease spread (WP2).
  3. Socioeconomic Impacts: Examining the effects of vaccination on society, including epidemiological, economic, welfare, and environmental dimensions (WP3).

The consortium consists of 20 high profile universitiesresearch institutions and companies. Coordination is at INRAE, France. The host institutions are located in Belgium, Egypt, France, Italy, Morocco, The Netherlands and The United Kingdom.

event

09 January 2025

Paris, France

VIVACE Kick-Off Meeting

On January 9th, our team met in Paris for the project's official kick-off meeting. It was an exciting start, bringing everyone together to share ideas, set goals, and plan the next steps. This meeting laid the groundwork for what promises to be an inspiring journey ahead!